chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an approximately 9-year-old male who on 04-SEP-1997 was vaccinated with a dose of Varivax (Oka/Merck) (lot# 623130/0568E). Subsequently, on an unspecified date, the patient developed a generalized rash of 50-200 lesions. He was seen by a physician but no hospitalization was involved. No outcome was reported. Additional information has been received on 05-JUL-2006 from an unspecified woman who indicated that no further information is available on this patient.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 10 year old female who was vaccinated with a dose of Varivax. In March 2006, the patient experienced breakthrough. At the time of the report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. The patient's sister experienced breakthrough following vaccination with Varivax (WAES# 0603USA03407). Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a woman from a physician's office concerning an 8 year old female who on 20-MAY-1999 was vaccinated with a dose of Varivax (Oka/Merck). Concomitant vaccinations included a dose of MMR II. On 28-MAR-2006 the patient was diagnosed with varicella, "no problem with it, mild case". At the time of the report the patient had not yet recovered. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a women at a health department concerning an 8-year-old male who on 09-FEB-1999 was vaccinated with a first dose of Varivax (Oka/Merck). It was reported that the patient received his second dose of Varivax (Oka/Merck) on 10-FEB-2006. On 17-FEB-2006 the patient developed a rash. It was noted that the school nurse diagnosed with child but it was unknown if he saw a physician. There was no duration or outcome reported. Additional information received on 12-JUL-2006 indicated that no further information is available. Additional information is not expected.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a woman at the health department concerning an 8-year-old white female who on 13-JUL-1999 was vaccinated with a dose of Varivax. Subsequently the patient developed a rash illness on an unspecified date. It was diagnosed and reported by the patient's mother. It is uncertain if medical attention was sought. No outcome information was reported. Follow-up information from the woman at the health department indicated that she had no further information on this patient. Additional information is not expected.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse (RN) concerning an 8-year-old white female who on 19-OCT-1998 was vaccinated with a dose of Varivax (lot# 627875/1245H). Subsequently the patient experienced a generalized rash of less than 50 lesions. Medical attention was sought and the patient was seen by a physician. No hospitalization was required. No outcome was reported. Additional information has been received from a woman who reported that no further information is available on this patient.
Age: 1.3
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old patient who on 07-SEP-2001 was vaccinated with a dose of Varivax. Subsequently, on an unspecified date, the patient developed suspect varicella. No further information is available.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Exposure to communicable disease, Rash generalised, Skin lesion
Clinical narrative: Information has been received from a health professional concerning an approximately 10 year old white male who on 01-FEB-2001 was vaccinated with Varivax (lot 636569/0926R). Subsequently, the patient experienced a generalized rash with <50 lesions. The case was documented or evaluated by a physician. The patient was not hospitalized. It was noted that he did have known contact with another case of varicella. No additional information was provided. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a health professional concerning a female who on 11-MAR-1999 was vaccinated with a dose of Varivax (Oka/Merck) (Lot# 627875/1245H). Subsequently the patient experienced rash of less than 50 lesions. The event was not documented/evaluated by a medical doctor. Follow-up information was received that indicated that there was no further information on this patient. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Skin lesion
Clinical narrative: Information has been received from a health professional concerning a white male who on 25-FEB-1999 was vaccinated with a dose of Varivax (Lot# 626786/0840M). It was reported that the patient developed a rash of less than 50 lesions. Unspecified medical attention was sought. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Exposure to communicable disease, Rash generalised
Clinical narrative: Information has been received from a health professional concerning a white female who on 11-DEC-1997 was vaccinated with a dose of Varivax (Lot# 624249/1103E). It was reported that the patient developed a generalized rash with less than 50 lesions. It was noted that the patient was in contact with another case of varicella. Unspecified medical attention was sought. No further information was available. Additional information is not expected.
Age: 1.5
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse (RN) concerning a white male who on 01-OCT-1998 was vaccinated with a dose of Varivax (Lot #627876/1241H). The RN reported that the patient subsequently developed a generalized rash. It was unknown if medical attention was sought and the patient was not hospitalized. At the time of this report, the outcome was unknown. No further information is available.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Vaccination failure
Clinical narrative: Information has been received from a women at the health department concerning a male, 7 years old at the time of the report, who on 10-MAR-1999 was vaccinated with a dose of Varivax (Oka/Merck) lot # "1743H". Subsequently the patient experienced "suspect varicella vaccine failure". The parents reported that the patient's brother had disease. No further information was provided. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Vaccination failure
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old white female who on 21-JUN-2000 was vaccinated with a dose of Varivax (lot # 634844/1869J). Subsequently, the patient experienced varicella vaccine failure. No further information was provided. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Vaccination failure
Clinical narrative: Information has been received from a woman at a health department concerning an approximately 6 year old white and black male who on 27-JUL-2000 was vaccinated with Varivax. Subsequently the patient experienced "suspect vaccine failure." It was unknown if medical attention was sought. No further information was provided. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Skin lesion
Clinical narrative: Information has been received from a health professional concerning an approximately 10 year old white female who was vaccinated with a dose of Varivax. Subsequently, the patient developed a generalized rash with 50-200 lesions. This case was documented or evaluated by a physician. The child was not hospitalized. No additional information was provided. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning an approximately 10 year old white female who on  28-OCT-1996 was vaccinated with a dose of Varivax. Subsequently, the patient experienced a generalized rash with < 50 lesions. This case was documented or evaluated by a physician. The child was not hospitalized. There was no other information provided. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Skin lesion
Clinical narrative: Information has been received from a health professional concerning a white female who on 02-APR-1996 was vaccinated with a dose of Varivax. It was noted that the patient developed a generalized rash with less than 50 lesions. The patient was not hospitalized and it was unknown if the case was documented by a physician. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning an approximately 10 year old female who on 25-MAR-1997 was vaccinated with a dose of Varivax. Subsequently, the patient experienced a generalized rash with 50-200 lesions. It was unknown if there was a cough or fever. This case was documented or evaluated by a physician. The child was not hospitalized. No additional information was provided. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old female who on 28-OCT-1996 was vaccinated with a dose of Varivax (Oka/Merck) (lot # 617908/0777D). On an unspecified date, the patient developed a generalized rash with 50 to 200 lesions. It was unknown if the patient had a fever or cough. It was unknown if the patient sought medication attention. No further information is available.
Age: 10.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old patient who on 20-NOV-1997 was vaccinated with a dose of Varivax (Oka/Merck). On an unspecified date, the patient developed a generalized rash with 50 to 200 lesions. It was unknown if the patient had a fever or cough or had known contact with another case of varicella. It was unknown if the patient sought medical attention. Follow-up information received on 03-AUG-2006 stated that no additional information is available on this patient.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Vaccination failure, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old female patient who on 03-MAY-2000 was vaccinated SC in the right thigh with a first dose of Varivax (Oka/Merck) (lot # 632369/1461J). The registered nurse indicated that the parent reported to the school nurse that on 15-MAR-2006, her child developed a rash which lasted for five days. Additional information received from the physician indicated that the patient experienced an "apparent vaccine failure", and that she was seen in March of 2006 with a clinical diagnosis of varicella. Subsequently, the patient recovered. No further information was available. Additional information is not expected.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning an 8 year old male with no known allergies or medical history who on 14-DEC-1998 was vaccinated IM in the left thigh with a first dose of Varivax (Oka/Merck) (lot# 626688/0650H). There was no concomitant medication of illness at the time of vaccination. On 06-FEB-2006 the patient experienced rash. Medical attention was not sought. No lab tests or diagnostic tests were performed. It was reported that the patient had no adverse events following prior vaccination. The patient's outcome was not reported. Additional information from the physician indicated that no further information is available regarding any adverse event.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old male who on 24-SEP-1997 was vaccinated with a dose of Varivax (Oka/Merck) (lot # 624089/0961E). On an unspecified date, the patient developed a generalized rash with less than 50 lesions. The patient was evaluated by a physician. Follow-up information received on 03-AUG-2006, stated that no further information was available on this patient.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old white male who on 01-DEC-1998 was vaccinated with a dose of Varivax. On an unspecified date, the patient developed a generalized rash with less than 50 lesions. It was unknown if the patient had a fever or cough. The patient was evaluated by a physician. Follow-up received on 03-AUG-2006 stated that no further information was available.
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised, Vaccination failure
Clinical narrative: Information has been received from a registered nurse concerning a white male who on 07-JUL-1997 was vaccinated with a dose of Varivax. Subsequently, the patient developed a generalized rash of 50-200 lesions. The patient was not hospitalized. Vaccine failure was noted. This was MD documented/evaluated. Follow-up information indicated that there was no further information. No additional information is expected.
Age: 1.6
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Vaccination failure
Clinical narrative: Information has been received from a health professional concerning a white female who on 27-AUG-1997 was vaccinated with a dose of Varivax (Lot # 623130/0568E). Subsequently, the patient developed a generalized rash of 50-200 lesions. It was unknown if a fever or cough were present. The patient was not hospitalized. This was MD documented/evaluated. Vaccine failure was noted. Follow-up information indicated that no further information was available. No additional information is expected.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Vaccination failure
Clinical narrative: Information has been received from a health professional concerning a 6-year-old white male who on 20-JUN-2000 was vaccinated with a dose of Varivax. On 30-JAN-2006 the patient experienced vaccine failure. It was noted that the child had known contact with another case of varicella. Follow up information indicated that no further information was available. No additional information is expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Vaccination failure
Clinical narrative: Information has been received from a health professional concerning a 7-year-old white male who on 19-AUG-1999 was vaccinated with a dose of Varivax (Lot # 626688/0650H). On 02-FEB-2006 the patient experienced a rash illness. It was unknown if this was MD documented/evaluated. This was noted as vaccine failure. Follow up information indicated that no further information was available. No additional information is expected.
Sex: F
Vaccine: VARCEL
Symptoms: Fatigue, Herpes zoster, Viral test
Clinical narrative: Information has been received from a physician concerning a female patient who on 08-DEC-1995 (also reported as 18-DEC-1995) was vaccinated in the left thigh with a 0.5 ml dose of Varivax (lot 610249/0745B). There was no rash at the site of injection or elsewhere within 42 days of the vaccination, no history of chickenpox, and no recent exposure to chickenpox or herpes zoster. On 01-APR-2006 the patient experienced herpes zoster on the left back T2-T4. The patient denies any temperature and rated pain a 6-7 out of 10. It was noted that the patient also had fatigue. On 06-APR-2006 a specimen was collected. It was an inadequate specimen with no strain ID. VZV DNA was amplified and B-globin was not amplified. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Vaccination failure
Clinical narrative: Information has been received from a woman at the department of health concerning a 6 year old female who on 27-JUL-2000 was vaccinated with Varivax (Oka/Merck) (lot 634842/1867J). Subsequently the patient experienced "suspect vaccine failure". It was unknown if medical attention was sought. No further information was provided. Additional information has been requested.
Age: 1.8
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a woman at the department of health concerning a 6 year old white male who on 21-MAR-2001 was vaccinated with Varivax (lot # 006BK). On 03-FEB-2006 the patient experienced a rash. It was noted that the school nurse observed the patient today and that the mother reported that the sister "had disease." No further information was provided. Additional information has been requested.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a health professional concerning an approximately 9 year old male who on 29-JUN-1998 was vaccinated with a dose of Varivax (Oka/Merck) (lot 625045/1573E). Subsequently, the patient experienced a rash with <50 lesions. This case was documented or evaluated by a physician. The child was not hospitalized. It was noted that the patient had known contact with another case of varicella. No additional information was provided. Additional information has been requested.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning an approximately 9 year old male who on 20-AUG-1998 was vaccinated with Varivax (Oka/Merck) (lot 626688/0650H). Subsequently, the patient experienced a generalized rash with <50 lesions. This case was documented or evaluated by a physician. The child was not hospitalized. No additional information was provided. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning an approximately 9 year old white male on 02-FEB-1998 was vaccinated with Varivax. Subsequently, the patient experienced a generalized rash with 50-200 lesions. The case was documented or evaluated by a physician. The child was not hospitalized. No additional information was provided. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning a patient who on 04-NOV-2004 was vaccinated with a dose of Varivax (Oka/Merck) (Lot # 645166/0347N). On 05-FEB-2006 the patient developed a generalized rash of <50 lesions. This was not localized at the injection site. A fever was noted for 1 day. No cough was noted. The patient was not hospitalized. There was no known contact with another case of varicella. This was noted to be vaccine failure. This was MD documented/evaluated. Follow up information indicated that no further information was available. No additional information is expected.
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning a male who on 30-AUG-2000 was vaccinated with a dose of Varivax (Oka/Merck) (Lot # 635188/0761K). On 04-JAN-2006, the patient developed a generalized rash of <50 lesions. The duration of the rash was 1 week. The patient was not hospitalized. This was noted to be vaccine failure. This was MD documented/evaluated. Follow up information indicated that no further information was available. No additional information is expected.
Age: 1.2
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Rash, Vaccination failure
Clinical narrative: Information has been received from a health professional concerning a 7-year-old white male who on 24-JAN-2000 was vaccinated with a dose of Varivax. On 09-FEB-2006 the patient developed a rash illness and was sent home from school. This was noted to be vaccine failure. It was unknown if this was MD documented/evaluated. Follow up information indicated that there was no further information. Additional information is not expected.
Age: 1.2
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a health professional concerning a 7-year-old white male who on 24-JAN-2000 was vaccinated with a dose of Varivax. On 09-FEB-2006 the patient developed a rash illness and was sent home from school. This was noted to be vaccine failure. It was unknown if this was MD documented/evaluated. Follow up information indicated that there was no further information. Additional information is not expected.
Age: 7.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Rash, Vaccination failure
Clinical narrative: Information has been received from a female concerning a 7-year-old male child who on 24-JAN-2000 was vaccinated with a dose of Varivax (Oka/Merck). On 09-FEB-2006 the patient started with a rash. It was reported that the school nurse diagnosed the patient and he was sent home from school on 09-FEB-2006. The duration of the rash was unknown and it was unknown if a physician documented or evaluated the rash. No outcome was reported. Additional information has been received from the physician's office. It was reported that they have not seen this patient since 2004 and have no record of a reaction following vaccination. No further information is expected.
Age: 7.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a female concerning a 7-year-old male child who on 24-JAN-2000 was vaccinated with a dose of Varivax (Oka/Merck). On 09-FEB-2006 the patient started with a rash. It was reported that the school nurse diagnosed the patient and he was sent home from school on 09-FEB-2006. The duration of the rash was unknown and it was unknown if a physician documented or evaluated the rash. No outcome was reported. Additional information has been received from the physician's office. It was reported that they have not seen this patient since 2004 and have no record of a reaction following vaccination. No further information is expected.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning a 7-year-old female who on 10-SEP-1999 was vaccinated with a dose of Varivax (Oka/Merck). Subsequently the patient developed a generalized rash illness. Vaccine failure was noted. It was unknown if this was MD evaluated/documented. Follow up information indicated that there was no further information. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration, Off label use, Rash
Clinical narrative: Information has been received from a health professional concerning a male who on 02-JUL-2001 was vaccinated with a dose of Varivax (Oka/Merck) (Lot # 635792/1893K). Subsequently the patient experienced rash illness. Vaccine failure was noted. This was MD documented/evaluated. Follow up information indicated that no further information was available. No additional information is expected.
Age: 34.0
Sex: M
Vaccine: VARCEL
Symptoms: Secondary transmission, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a child who was vaccinated with Varivax and developed a mild case of breakthrough chicken pox. (WAES # 0604USA00025) Subsequently, the patient's father, a 34 year old male, developed a full blown case of chicken pox and had to be hospitalized for 5 days. No additional information was provided. Additional information ahs been requested.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 10 year old male who was vaccinated with a subcutaneous dose of Varivax. Subsequently, the patient developed chickenpox (100 lesions). Unspecified medical attention was sought. The outcome of the patient was not reported. There was no product quality complaint involved. NO further information was provided. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a health professional concerning a male patient who was vaccinated with a dose of Varivax. Subsequently the patient experienced breakthrough chickenpox with 50 lesions. At the time of the report the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected.
Age: 1.4
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash, Rash papular, Rash vesicular
Clinical narrative: Information has been received from a nurse practitioner concerning a 7-year-old white female with drug reactions or allergies to AUGMENTIN, codeine, and KEFLEX and no other pertinent medical history who on 05-JUN-2000 was vaccinated with a subcutaneous 0.5 mL dose in the left arm of Varivax (lot # 634842/1867J). Concomitant therapy that day included a dose of MMR II. There was no other concomitant medication. On 02-APR-2006 the patient developed chickenpox breakthrough rash. The rash was seen on her arms, legs, back, and chin. The lesions were papular-vesicular. The child had a fever to 99.7. Unspecified medical attention was sought and she was treated with BENADRYL as needed and monitoring. As of 04-APR-2006 the patient was recovering. A product quality complaint was not involved. Additional information has been received from a medical assistant who reported that on 03-APR-2006 the patient had eight scattered papular-vesicular lesions. BENADRYL was given on her extremities and face. It was noted that she was exposed to chickenpox at school. The patient recovered on 08-APR-2006. Additional information is not expected.
Age: 1.4
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse practitioner concerning a 7-year-old white female with drug reactions or allergies to AUGMENTIN, codeine, and KEFLEX and no other pertinent medical history who on 05-JUN-2000 was vaccinated with a subcutaneous 0.5 mL dose in the left arm of Varivax (lot # 634842/1867J). Concomitant therapy that day included a dose of MMR II. There was no other concomitant medication. On 02-APR-2006 the patient developed chickenpox breakthrough rash. The rash was seen on her arms, legs, back, and chin. The lesions were papular-vesicular. The child had a fever to 99.7. Unspecified medical attention was sought and she was treated with BENADRYL as needed and monitoring. As of 04-APR-2006 the patient was recovering. A product quality complaint was not involved. Additional information has been received from a medical assistant who reported that on 03-APR-2006 the patient had eight scattered papular-vesicular lesions. BENADRYL was given on her extremities and face. It was noted that she was exposed to chickenpox at school. The patient recovered on 08-APR-2006. Additional information is not expected.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a certified medical assistant concerning a 11 year old female who on 19-APR-1996, was vaccinated with a subcutaneous dose of Varivax (Oka/Merck). Concomitant therapy included methylphenidate HCl (RITALIN). On 05-APR-2006, the patient broke out with 25 varicella lesions all over her body. She did not have a fever and no treatment was given. As of 05-APR-2006, the patient was recovering. No laboratory or diagnostic tests were performed. Follow-up information from a physician indicated that on 02-APR-2006 the patient developed chickenpox, which she then transmitted to her mother (WAES# 0609USA06665). It was noted that the patient was seen in the physician's office. It was reported that the patient had recovered. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a 35 year old female with no allergies or medical history who in May or June 2005 was vaccinated with a dose of Varivax (Oka/Merck) (lot # 648087/0099P). There was no concomitant medication. "Last week", in approximately March 2006, the patient had "lab work" done which showed she had no antibodies. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 5-year-old female with no pertinent medical history and no drug reactions/allergies who on 25-MAY-2001 was vaccinated with a dose of Varivax (Oka/Merck) (Lot # 637663/1602K). There was no illness at the time of vaccination. There was no concomitant medication. It was noted that on 24-AUG-2001 and 13-OCT-2004, the patient was vaccinated SC in the left arm with doses of MMR II (Lot # 639517/0592L and Lot # 648471/0321P, respectively). On 04-APR-2006 the patient developed a breakthrough case of varicella. She had about 25 lesions on her face, arms, and abdomen. They were itchy and the doctor prescribed diphenhydramine hydrochloride (BENADRYL). She had no other symptoms and has recovered. There were no lab diagnostic studies performed. There was no product quality complaint. Follow up information received from a registered nurse indicated that on 04-APR-2006 the patient developed varicella disease. On 10-APR-2006, the patient recovered. No additional information is expected.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a registered nurse concerning a 37 month old female with no known drug allergies and no pertinent medical history who on 27-FEB-2004 was vaccinated SQ with 0.5 mL dose of Varivax (Oka/Merck) (lot# 647093/0886N). There was no concomitant medication. On 30-MAR-2006 the patient developed herpes zoster lesions on the back of the right thigh. No diagnostic/laboratory tests performed. Unspecified medical attention was sought. The patient was treated with acyclovir therapy. As of 06-Apr-2006, the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 37 month old male with a penicillin allergy resulting in hives and no other medical history who on 25-MAR-2004 was vaccinated SC with a first dose of Varivax (Oka/Merck) (lot # 647709/1247N). There was no concomitant medication. There was no illness at the time of vaccination. On 04-APR-2006 the patient experienced breakthrough varicella. He had about 15 lesions on the back of his arms and legs that were itchy. Diphenhydramine hcl (BENADRYL) was prescribed and no labs or diagnostic tests were done. The patient recovered on 14-APR-2006. Medical attention was sought and no product quality complaint was involved. Additional information has been requested.
Age: 1.4
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Information has been received from a physician concerning a 6 year old female with no pertinent medical history who on 27-DEC-2000 was vaccinated with a dose of Varivax (lot # 635443/0498K). On 01-APR-2006 the patient experienced a chickenpox rash. The child presented to the physician's office with a "chickenpox" rash with less than 50 lesions. There was no treatment ordered and there was no fever or other symptoms. At the time of this report the patient was recovering. There was no product quality complaint involved. Additional information has been requested.
Age: 0.9
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Skin lesion
Clinical narrative: Information has been received from a health professional concerning an approximately 10 year old white female who in August 1996 was vaccinated with Varivax (lot 617265/0566D). Subsequently, the patient experienced a generalized rash with < 50 lesions. It was unknown if the case was documented or evaluated by a physician. The child was not hospitalized. No additional information was provided. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Vaccination failure
Clinical narrative: Information has been received from a registered nurse concerning a white female who on 08-APR-1996 was vaccinated with a dose of Varivax (Lot # 612226/1501B). Subsequently, the patient developed a generalized rash of 50-200 lesions. The patient was not hospitalized. Vaccine failure was noted. This was MD documented / evaluated. Follow up information indicated that no further information was available. No additional information is expected.
Sex: M
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a health professional concerning a male who on 18-APR-1996 was vaccinated with a dose of Varivax (Oka/Merck). Subsequently the patient experienced a generalized rash with 50-200 lesions. Unspecified medical attention was sought.  Follow-up information from a health professional indicated that no further information was available. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a child who was vaccinated with Varivax (Oka/Merck). "In the past 2 weeks", in approximately March 2006, the patient experienced breakthrough chicken pox with more than 100 lesions. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning her 24-month-old daughter who on 25-MAR-2006 was vaccinated with a dose of Varivax (Oka/Merck). On 28-MAR-2006 the patient experienced varicella lesions on her chest, trunk, and extremities. No other information was provided. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash generalised, Skin lesion
Clinical narrative: Information has been received from a registered nurse concerning an 11-year-old female who on 12-MAR-1996 was vaccinated with a dose of Varivax (Oka/Merck). On an unspecified date, the patient developed a generalized rash with 50 to 200 lesions. It was unknown if medical attention was sought. Additional information has been received from the registered nurse which indicated that she had no further information.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a registered nurse concerning an approximately 11 year old white male who on 20-MAY-1996 was vaccinated with a dose of Varivax (lot # not provided). Subsequently, the patient developed 50-200 lesions. The patient's outcome was not reported. This case was MD documented/evaluated. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Blister, Body temperature increased, Cellulitis, Eye discharge, Henoch-Schonlein purpura
Clinical narrative: Information has been received from a physician concerning a 5 year old female with no known medical history who on 26-OCT-2001 was vaccinated SC in the right arm with a first dose of Varivax (lot # 6440312/0795L). Concomitant vaccination included a first dose of MMR II (Lot # 639518/0898L) given SC in the left arm and a fourth dose of PREVNAR (lot # 481548) given IM in the right thigh. There was no illness at the time of vaccination. On 31-MAR-2006 the patient presented to the office with severe shingles involving her right arm - shoulder to fingertips, which started in the morning on 30-MAR-2006. Follow-up information from the physician indicated that on 29-MAR-2006 the patient developed a red vesicular rash on her right arm. On 31-MAR-2006 the patient was seen by the physician with a painful rash all over. Temperature was 100.2, no fever was noted at home. The rash was painful and she was not using her arm. No itching was noted. The patient was diagnosed with severe shingles from her shoulder to her palm. Thick clusters  with bright red bases were noted. Some swelling was noted in the palm of her hand. She was treated with acyclovir 2 tsp qid X 5 days, acyclovir ointment qid and acetaminophen (+) hyrcocodone bitartrate (LORTAB) suspension 1 tsp every 4-6 hours for 3 days. It was reported that the patient did not have any history of chickenpox and there was no known recent exposure to chickenpox or herpes zoster. On 03-APR-2006 she was seen for a recheck and it was reported that she was better. Decreased redness was noted at the base of the lesions. Swelling of her right hand was still noted and she was not using her arm. The physician's assessment was resolving shingles. On 07-APR-2006 the patient's mother was called for an update and she reported that the arm, shingles were scabbed up and look better. Her hands were still swollen. The spots on her hand and palm hurt and were raised. The patient was seen because her hand was still swollen, red and painful. Physical examination showed dry/scabbed shingles lesions on her right arm, right hand still swollen and redness was noted on her thumb. Decreased ROM was noted on her thumb and her thumb and forefinger were tender. The assessment was cellulitis right hand and she was treated with amoxicillin (+) clavulanate potassium (AUGMENTIN ES-600) 1 po BID. On 10-APR-2006 the patient's mother stated that her arm looked better. Blisters on palm were now reddish brown and scabbed over. She was using her hand a little more. The physician's plan was to continue antibiotics and watch. On 12-APR-2006 it was reported that the patient recovered. Follow-up information received on 20-JUN-2006 contained the following adverse experiences: henoch schonlein purpura (January 2004) and right eye red, draining (28-APR-2005). Upon internal review the patient's henoch schonlein purpura was considered to be an other important medical event. No further information is available.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Herpes zoster, Joint range of motion decreased, Ocular hyperaemia, Oedema peripheral, Pain
Clinical narrative: Information has been received from a physician concerning a 5 year old female with no known medical history who on 26-OCT-2001 was vaccinated SC in the right arm with a first dose of Varivax (lot # 6440312/0795L). Concomitant vaccination included a first dose of MMR II (Lot # 639518/0898L) given SC in the left arm and a fourth dose of PREVNAR (lot # 481548) given IM in the right thigh. There was no illness at the time of vaccination. On 31-MAR-2006 the patient presented to the office with severe shingles involving her right arm - shoulder to fingertips, which started in the morning on 30-MAR-2006. Follow-up information from the physician indicated that on 29-MAR-2006 the patient developed a red vesicular rash on her right arm. On 31-MAR-2006 the patient was seen by the physician with a painful rash all over. Temperature was 100.2, no fever was noted at home. The rash was painful and she was not using her arm. No itching was noted. The patient was diagnosed with severe shingles from her shoulder to her palm. Thick clusters  with bright red bases were noted. Some swelling was noted in the palm of her hand. She was treated with acyclovir 2 tsp qid X 5 days, acyclovir ointment qid and acetaminophen (+) hyrcocodone bitartrate (LORTAB) suspension 1 tsp every 4-6 hours for 3 days. It was reported that the patient did not have any history of chickenpox and there was no known recent exposure to chickenpox or herpes zoster. On 03-APR-2006 she was seen for a recheck and it was reported that she was better. Decreased redness was noted at the base of the lesions. Swelling of her right hand was still noted and she was not using her arm. The physician's assessment was resolving shingles. On 07-APR-2006 the patient's mother was called for an update and she reported that the arm, shingles were scabbed up and look better. Her hands were still swollen. The spots on her hand and palm hurt and were raised. The patient was seen because her hand was still swollen, red and painful. Physical examination showed dry/scabbed shingles lesions on her right arm, right hand still swollen and redness was noted on her thumb. Decreased ROM was noted on her thumb and her thumb and forefinger were tender. The assessment was cellulitis right hand and she was treated with amoxicillin (+) clavulanate potassium (AUGMENTIN ES-600) 1 po BID. On 10-APR-2006 the patient's mother stated that her arm looked better. Blisters on palm were now reddish brown and scabbed over. She was using her hand a little more. The physician's plan was to continue antibiotics and watch. On 12-APR-2006 it was reported that the patient recovered. Follow-up information received on 20-JUN-2006 contained the following adverse experiences: henoch schonlein purpura (January 2004) and right eye red, draining (28-APR-2005). Upon internal review the patient's henoch schonlein purpura was considered to be an other important medical event. No further information is available.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Rash vesicular, Tenderness
Clinical narrative: Information has been received from a physician concerning a 5 year old female with no known medical history who on 26-OCT-2001 was vaccinated SC in the right arm with a first dose of Varivax (lot # 6440312/0795L). Concomitant vaccination included a first dose of MMR II (Lot # 639518/0898L) given SC in the left arm and a fourth dose of PREVNAR (lot # 481548) given IM in the right thigh. There was no illness at the time of vaccination. On 31-MAR-2006 the patient presented to the office with severe shingles involving her right arm - shoulder to fingertips, which started in the morning on 30-MAR-2006. Follow-up information from the physician indicated that on 29-MAR-2006 the patient developed a red vesicular rash on her right arm. On 31-MAR-2006 the patient was seen by the physician with a painful rash all over. Temperature was 100.2, no fever was noted at home. The rash was painful and she was not using her arm. No itching was noted. The patient was diagnosed with severe shingles from her shoulder to her palm. Thick clusters  with bright red bases were noted. Some swelling was noted in the palm of her hand. She was treated with acyclovir 2 tsp qid X 5 days, acyclovir ointment qid and acetaminophen (+) hyrcocodone bitartrate (LORTAB) suspension 1 tsp every 4-6 hours for 3 days. It was reported that the patient did not have any history of chickenpox and there was no known recent exposure to chickenpox or herpes zoster. On 03-APR-2006 she was seen for a recheck and it was reported that she was better. Decreased redness was noted at the base of the lesions. Swelling of her right hand was still noted and she was not using her arm. The physician's assessment was resolving shingles. On 07-APR-2006 the patient's mother was called for an update and she reported that the arm, shingles were scabbed up and look better. Her hands were still swollen. The spots on her hand and palm hurt and were raised. The patient was seen because her hand was still swollen, red and painful. Physical examination showed dry/scabbed shingles lesions on her right arm, right hand still swollen and redness was noted on her thumb. Decreased ROM was noted on her thumb and her thumb and forefinger were tender. The assessment was cellulitis right hand and she was treated with amoxicillin (+) clavulanate potassium (AUGMENTIN ES-600) 1 po BID. On 10-APR-2006 the patient's mother stated that her arm looked better. Blisters on palm were now reddish brown and scabbed over. She was using her hand a little more. The physician's plan was to continue antibiotics and watch. On 12-APR-2006 it was reported that the patient recovered. Follow-up information received on 20-JUN-2006 contained the following adverse experiences: henoch schonlein purpura (January 2004) and right eye red, draining (28-APR-2005). Upon internal review the patient's henoch schonlein purpura was considered to be an other important medical event. No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from an employee in a physician's office concerning a 5 year old white male with no known allergies, birth defects, or medical conditions who on 30-MAR-2001 was vaccinated SC with a first dose of Varivax in another physician's office. On 05-MAR-2006 the patient developed varicella lesions "also in mouth." Medical attention was not sought. Subsequently the patient recovered. Additional information is not expected.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 35 month old male who in June 2004 was vaccinated with a dose of Varivax (lot # not reported). Subsequently the patient developed mild breakthrough chickenpox characterized by less than 50 lesions. The patient's outcome was not reported. There was no product quality complaint involved. Follow-up information from the registered nurse indicated that she did not know who the patient was and that she did not report this event. Additional information is not expected.
Age: 44.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Diagnostic procedure
Clinical narrative: Information has been received from a health professional concerning a 44 year old female employee with environmental allergies who in approximately 1998, approximately 8 years ago, was vaccinated with two doses of Varivax. On 04-APR-2006 the patient failed an antibody test. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a health professional concerning a child in twelfth grade who was vaccinated with a dose of Varivax. "Recently," in 2006, the patient experienced shingles. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Blood human chorionic gonadotropin positive, Injection site mass, Pregnancy test positive
Clinical narrative: Information has been received through the Merck pregnancy registry from a 35 year old female, with no medical history and no allergies, who was vaccinated with a first and second dose of Varivax on 21-FEB-2006 and 21-MAR-2006, respectively. There was no concomitant medication. It was noted that the patient had pregnancy tests on each of the days that she was vaccinated and both of the pregnancy tests were positive. "One day after the second vaccination with Varivax," on 22-FEB-2006, the patient developed a red lump at the injection site, that went away within one week, and was considered to be recovered on 28-MAR-2006. It was reported that a pregnancy test done on 06-APR-2006 was positive. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested. 02/11/2010 No further information is available.